Literature DB >> 28688774

Prioritizing the patient voice in the development of urologic oncology research.

Pauline Filippou1, Angela B Smith2.   

Abstract

Prioritization of patient and stakeholder engagement in the research process has been realized through increased funding and policy directives at the government level. Particularly, patient engagement in the preparatory research stage has driven development of patient-prioritized research questions. In this article, a successful example of patient-centered research prioritization is reviewed, and effective strategies and opportunities for patient engagement in urologic oncology research are described.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Engagement; Patient participation; Patient-centered care; Urologic neoplasms

Mesh:

Year:  2017        PMID: 28688774     DOI: 10.1016/j.urolonc.2017.06.045

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  3 in total

1.  Defining Priorities to Improve Patient Experience in Non-Muscle Invasive Bladder Cancer.

Authors:  Tullika Garg; Jill Nault Connors; Ilene G Ladd; Tyler L Bogaczyk; Sharon L Larson
Journal:  Bladder Cancer       Date:  2018-01-20

2.  Utilizing patient advocates in Parkinson's disease: A proposed framework for patient engagement and the modern metrics that can determine its success.

Authors:  Megan Feeney; Christiana Evers; Danielle Agpalo; Lisa Cone; Jori Fleisher; Karlin Schroeder
Journal:  Health Expect       Date:  2020-05-03       Impact factor: 3.377

3.  Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.

Authors:  Sarah Barger; Sean D Sullivan; Ari Bell-Brown; Brad Bott; Anne Marie Ciccarella; John Golenski; Mark Gorman; Judy Johnson; Karma Kreizenbeck; Florence Kurttila; Ginny Mason; Jamie Myers; Carole Seigel; James L Wade; Guneet Walia; Kate Watabayashi; Gary H Lyman; Scott D Ramsey
Journal:  BMC Med Res Methodol       Date:  2019-06-11       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.